Imeik Technology Development Co.,Ltd.

Shenzhen Stock Exchange 300896.SZ

Imeik Technology Development Co.,Ltd. Free Cash Flow Yield on January 14, 2025: 3.70%

Imeik Technology Development Co.,Ltd. Free Cash Flow Yield is 3.70% on January 14, 2025, a -6.11% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Imeik Technology Development Co.,Ltd. 52-week high Free Cash Flow Yield is 5.77% on July 08, 2024, which is 55.82% above the current Free Cash Flow Yield.
  • Imeik Technology Development Co.,Ltd. 52-week low Free Cash Flow Yield is 2.20% on October 08, 2024, which is -40.58% below the current Free Cash Flow Yield.
  • Imeik Technology Development Co.,Ltd. average Free Cash Flow Yield for the last 52 weeks is 4.02%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
Shenzhen Stock Exchange: 300896.SZ

Imeik Technology Development Co.,Ltd.

CEO Mr. Yifeng Shi
IPO Date Sept. 28, 2020
Location China
Headquarters Shimao Building
Employees 910
Sector Consumer Discretionary
Industries
Description

Imeik Technology Development Co.,Ltd focuses on the research and development, production, and sale of biomedical materials. The company offers medical beauty field products, including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. It also offers skin care products, including moisturizing lotions, anti-wrinkle firming kinetic energy liquids, essence creams, hydrating firming masks, chitosan B5 repair sprays, and purifying and brightening kinetic liquids. The company was founded in 2004 and is based in Beijing, China.

Similar companies

300122.SZ

Chongqing Zhifei Biological Products Co., Ltd.

USD 3.45

3.36%

300015.SZ

Aier Eye Hospital Group Co., Ltd.

USD 1.73

3.02%

300760.SZ

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

USD 32.18

1.97%

688363.SS

Bloomage BioTechnology Corporation Limited

USD 6.87

3.48%

StockViz Staff

January 15, 2025

Any question? Send us an email